Navigation Links
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
Date:10/1/2007

stop eating," stated Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech. "The Phase 2 trial that we are initiating is designed to demonstrate the effectiveness of PYY nasal spray in promoting weight loss which, if successful in development and approval, could help treat what has become an international health epidemic affecting hundreds of millions of people worldwide."

About PYY

Peptide YY is a naturally occurring hormone that is believed to function as a physiologic inhibitor of food intake. PYY is released into the blood stream from specialized endocrine cells (L-cells) in the gut after a meal and is believed to trigger the feeling of satiety, or fullness. Because PYY is a peptide, initial studies focused on PYY delivery by injection. Utilizing its proprietary drug delivery technology, Nastech developed the nasal spray formulation of PYY as a unique, non-invasive treatment option for obesity.

About Obesity

There are approximately 1.6 billion overweight adults worldwide, 400 million of whom are clinically obese according to World Health Organization. Obesity contributes to increased risk for chronic diseases including type 2 diabetes, cardiovascular disease and hypertension. PYY nasal spray may offer a novel treatment option for those suffering from this condition.

About Nastech

Nastech is a biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.

Nastech Forward Looking Statements

Statements made in this press release may be forward-looking statements within the meaning of Federal Securities laws that are subj
'/>"/>

SOURCE Nastech Parmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).../ -- America,s Specialty Medicines Companies (ASMC...ller innovator pharmaceutical companies, today exp...ealth Care for America Act," introduced by House D...ear that the cumulative effect of a host of provis...ng new medicines to market. ,, From required ...
(Date:11/6/2009)...all/ -- Virtual Health Technologies, Inc. (OTC Bul...usly confirmed Letter of Intent to sell all health...ies, Inc (WNDM) is subject to final approval of t...,, Shareholder Assurances ,, "We believe t...nd cash realized from the transaction would benefi...
(Date:11/6/2009)...ewswire/ -- Chimerix, Inc., a biopharmaceutical co...utics to address life-threatening diseases, presen...ad antiviral compound, CMX001, to the World Health... Initiative (GHSI). CMX001 is a broad-spectrum an... smallpox, as well as other serious viral infectio...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 58541 1Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 58541 2Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 58541 3Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 1Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 2Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 3Ann Taylor Supports The Fight Against Breast Cancer 58535 1Ann Taylor Supports The Fight Against Breast Cancer 58535 2
...PA for an oncolytic product, WOBURN, Mass., April...g clinical stage treatments for cancer and the pre...t the U.S. Food and Drug,Administration (FDA) has ...I clinical trial evaluating its lead product, Onco...tastatic melanoma. The agreement was,made under th...
... - Summary: Using Protein Tomography(TM), Sidec I...ular Mode of Action of Humax- EGFr,(Zalutumumab). ...nd That,Zalutumumab Locks the EGFr Into a Very Com... Signaling and Cancer Cell Growth., Sidec AB anno...r mode,of action of HuMax-EGFr (zalutumumab) has b...
Other Medicine Technology:BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 2BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 3Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS 2
(Date:11/7/2009)... In the current economic climate, many American... only spending money on what that they consider to...eon David D. Kim believes that it’s very im...receive treatment to improve their health, and he ...o patients in this tough economy by offering reaso...
(Date:11/6/2009)...ntly a Narconon of Georgia graduate was featured i...cription drug abuse. The special report focused on...ion . In the report Andrew shared his near death...e to prevent prescription drug abuse. ,, "I woke u... my eyes to my father on top of me giving me CPR. ...
(Date:11/6/2009)...ntene Corporation (NYSE: CNC ) today announced th...erences over the next few weeks. ,, Next week, at ...ce, to be held November 11-13, 2009, at the Arizon... present Wednesday, November 11th at 4:30 p.m. Mou... may access Centene,s presentation at: http://w....
(Date:11/6/2009)...p Hundreds of Thousands of Idahoans Struggling wit...ance Premiums ,, BOISE, Idaho, Nov. 6 As the ...itch and the House readies to vote on critical hea...ARP is calling on Idaho,s U.S. Representatives to ...th Care for America Act (H.R. 3962), which will cl...
(Date:11/6/2009)... A survey released today from Jackson Healthcar... (74 percent) feel they have less control over the...rs ago. , Alpharetta, GA ...y from Jackson Healthcare reports that the major...have less control over the way they practice medic...
Breaking Medicine News(10 mins):Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2Health News:AARP Calls On Idaho's U.S. Reps To Back House Health Care Reform Bill 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4
...c transplantation is done as a therapeutic option ... whether this transplant is effective has been con...who receive a pancreas transplant appear to have w...tic transplant for patients who have had or need a...
...rs have identified a molecule that may help older ...rs studied a group of cells, called satellite cell...ells rescue damaged muscles and divide to form new...ch is activated by another protein called Delta. ...
...rch reports, patients who were treated for depress... vitamin B12 in their blood.// An increasing am...ween vitamin B and depression, but the specifics h...ed 115 patients who suffered from depression. Over...
...udy published in the British Medical Journal sugge...a pulmonary embolism in an otherwise healthy young...ood clot that developed elsewhere in the body trav... have shown an association between blood clots and...
...rs publishing in the most recent issue of The Lanc...tment for the deadly Ebola virus.// In a stu...injections of a factor known to inhibit blood coag...sive coagulation of the blood and, ultimately, org...
... use menstrual cycle monitors to detect their fert...es carefully because some methods are much more re...ate 10 percent to 15 percent of women of reproduct...itor to detect their fertile times for either conc...
Other Medicine News:Health News:Pancreas Transplant for Diabetics 2Health News:Accuracy of Some Natural Family Planning Methods Questioned . 2
Allen® Delux Arthroscopic Legholder System
...opy. Ease of use and superior performance are the ... unique. , ,The 10k Fluid System, when used for Ar...le providing instantaneous flow and overpressure c...scopy, provides instantaneous fluid flow or suctio...
...ives you an entirely new way to visualize, edit, s... perfect tool for turning real-life surgery into l...and footswitch, you can record only the parts of t... video tapes. With your finished DVD, you can tran...
Sony PVM
Medicine Products: